《恶性肿瘤的分子生物学.ppt》由会员分享,可在线阅读,更多相关《恶性肿瘤的分子生物学.ppt(52页珍藏版)》请在第壹文秘上搜索。
1、Subcellular distribution of v 6图1 卵巢肿瘤A:GAe组雏鸡接种MDV GA株后40天,卵巢形成明显肿瘤(如箭头所示);B:GA0组卵巢正常(如箭头所示);C:异常卵巢和正常卵巢的直观比较) 图2 睾丸肿瘤A:GA0组睾丸正常(如箭头所示);B:GAe组雏鸡接种MDV GA株后40天,睾丸形成明显肿瘤(如箭头所示); C:异常睾丸和正常睾丸的直观比较) l对肿瘤发生的分子机制,最初人们认为是对肿瘤发生的分子机制,最初人们认为是病毒瘤基因病毒瘤基因所致;所致;l7070年代中期,毕晓普和瓦慕斯发现动物正年代中期,毕晓普和瓦慕斯发现动物正常细胞中本来存在常细胞中本来
2、存在癌基因(原癌基因)癌基因(原癌基因);l正常情况下,瘤基因对细胞的生长、分化、正常情况下,瘤基因对细胞的生长、分化、调节和维护正常功能起重要作用;调节和维护正常功能起重要作用;l近来发现细胞中有抑制肿瘤发生的近来发现细胞中有抑制肿瘤发生的抑瘤基抑瘤基因因。The vast majority of these mutations are somaticExampleOncogenes derived from growth factor receptors confer the ability to bypass the growth factor requirementleading to
3、 independent growth.Act as a brake for cell division“GUARDIAN OF THE GENOME”PROBLEM:Mutation in tumour suppressor genes = brakes dont work, or there is an accumulations of mutations (DNA repair enzymes)The mutated gene product is not functional = NULL ALLELEInactivated tumour suppressor gene肿瘤发生肿瘤发生
4、Activated proto-oncogenel细胞癌基因(细胞癌基因(cellular oncogenes,C-onc):存在于动物:存在于动物细胞中的癌基因。正常情况下主要在胚胎期表达,在出细胞中的癌基因。正常情况下主要在胚胎期表达,在出生后的个体内不表达或限量表达,主要功能是促进细胞生后的个体内不表达或限量表达,主要功能是促进细胞的正常增殖和分化,又称的正常增殖和分化,又称原癌基因原癌基因,被致癌因素激活时,被致癌因素激活时,可诱导细胞癌变,可诱导细胞癌变。含转录含转录启动子启动子 LTR gag pol env src LTR 长末端长末端重复序列重复序列癌基因癌基因正常的病毒基因正
5、常的病毒基因 产生病毒产生病毒表面糖蛋白表面糖蛋白产生逆转录产生逆转录酶和整合酶酶和整合酶 产生病毒产生病毒 垮膜蛋白垮膜蛋白产生产生p60p60srcsrc蛋白质,蛋白质,磷酸化蛋白。靶蛋磷酸化蛋白。靶蛋白磷酸化白磷酸化Rous于于1910年首先发现鸡肉瘤病毒(后称劳年首先发现鸡肉瘤病毒(后称劳斯肉瘤病毒斯肉瘤病毒RSV)基因扩增基因扩增蛋白质结构未变化,但总量大大提高蛋白质结构未变化,但总量大大提高基因扩增基因扩增 原癌基因原癌基因基因在细胞中拷贝数增加,从而使可用的转基因在细胞中拷贝数增加,从而使可用的转录模板数大大增加。录模板数大大增加。染色体易位或重排染色体易位或重排慢性粒细胞白血症
6、慢性粒细胞白血症(Chronic myeloid leukaemia,CML) is characterised bythe t(9;22)(q34;q11) reciprocal translocation病毒病毒启动子启动子插入插入基因间相互作用基因间相互作用 肿瘤细胞中常常不是由一种肿瘤细胞中常常不是由一种C-onc表达异常,表达异常,有时需几种有时需几种C-onc发生改变,产生协同作用方发生改变,产生协同作用方可奏效可奏效 正常细胞的基因,具有相对稳定的甲基正常细胞的基因,具有相对稳定的甲基化类型,特别是原癌基因的甲基化可使其难化类型,特别是原癌基因的甲基化可使其难以表达。以表达。 原
7、癌基因甲基化水平降低原癌基因甲基化水平降低Examples of Oncogenes抑癌基因在染色体中起稳定性作用;抑癌基因在染色体中起稳定性作用;参与细胞分化以控制肿瘤形成,细胞的终末参与细胞分化以控制肿瘤形成,细胞的终末 分化可抑制细胞分裂;分化可抑制细胞分裂;参与衰老过程,诱导细胞程序性死亡;参与衰老过程,诱导细胞程序性死亡;通过调控细胞周期,调节细胞增殖。通过调控细胞周期,调节细胞增殖。正常情况下抑癌基因的作用:正常情况下抑癌基因的作用:抑癌基因改变的分子基础抑癌基因改变的分子基础错配修复基因缺陷错配修复基因缺陷 守门基因和看护基因的突变失活守门基因和看护基因的突变失活 守门基因守门基
8、因(gatekeeper gene)是指在细胞恶是指在细胞恶性转化过程中与癌基因启动相关的基因。性转化过程中与癌基因启动相关的基因。 看护基因看护基因(caretaker,gene)是指保持细胞是指保持细胞基因组稳定性,而与细胞恶性转化过程中癌基基因组稳定性,而与细胞恶性转化过程中癌基因的启动不直接相关的基因。因的启动不直接相关的基因。Examples of tumour suppressor genes includeRB1 - retinoblastoma susceptibility gene WT1 - Wilms tumour gene NF1 - neurofibromatosis
9、 type 1 gene NF2 - neurofibromatosis type 2 gene DCC - involved in colorectal cancer BRCA1, BRCA2 - involved in breast cancerToday we will look at these tumour suppressor genes:Rb ( () )p53APC ( (腺瘤样结肠息肉腺瘤样结肠息肉) )p53 functions as a molecular node in the DNA-damage response恶性肿瘤细胞在生物学研究中的应用恶性肿瘤细胞在生物学研
10、究中的应用 无限制增长特性无限制增长特性 细胞分化幼稚细胞分化幼稚 细胞寿命长细胞寿命长 细胞的侵润性细胞的侵润性 致瘤性致瘤性 细胞的遗传性细胞的遗传性Clonal selection of cancer cellsVariants over timeThe molecular mechanisms involved in classical cross-priming are illustrated. Dendritic cells (DCs) take up antigen by distinct endocytosis mechanisms and present it to CD4+
11、 T helper (TH) cells through MHC class II molecules and cross-present it to CD8+ cytotoxic T lymphocytes (CTLs) through MHC class I molecules. Activated CD4+ TH cells can stimulate CTLs through the production of interleukin-2 (IL-2) and license DCs for cross-priming through CD40 ligand (CD40L)CD40 i
12、nteractions. Licensed DCs upregulate expression of co-stimulatory molecules, such as CD70, CD80 and CD86, and downregulate inhibitory molecules, such as programmed cell death ligand (PDL1). Toll-like receptor (TLR) ligands further activate DCs and increase their cross-presentation activity. Cross-pr
13、imed CTLs are programmed for survival and cease TNF-related apoptosis-inducing ligand (TRAIL) production. Helpless CTLs activated by unlicensed DCs die following secondary encounter with antigen in their effector phaseChemokine-mediated regulation of cross-priming is illustrated. CD4+ TH cells, and
14、the DCs they license, produce CC-chemokine ligand 3 (CCL3), CCL4 and CCL5 in the presence of TLR ligands, which recruit naive CTLs for classical cross-priming. Alternatively, DCs licensed by natural killer T (NKT) cells produce the CC-chemokine receptor (CCR4) ligand CCL17, and NKT cells themselves
15、produce the CCR4 ligand CCL22, which recruit naive CCR4+ CTLs for cross-priming. The CCR4- and CCR5-mediated recruitment pathways are synergistic. In this figure, dashed arrows indicate antigen routing for crosspresentation. -GalCer, -galactosylceramide; TCR, T cell receptor.Recruitment of cross-pri
16、med effector cytotoxic T lymphocytes into non-lymphoid tissues. Viral infection of tissue cells leads to their secretion of pro-inflammatory cytokines and interferons that upregulate the expression of adhesion molecules, such as intercellular adhesion molecule 1 (ICAM1), by endothelial cells. Effector cytotoxic T lymphocytes (CTLs) attach to these molecules and are nonspecifically recruited from the bloodstream into non-lymphoid tissues. In addition, recent studies have revealed two antigen-spec